ATAC-seq of human gastric adenocarcinoma NCI-N87 cell line treated with lapatinib
Source: NCBI BioProject (ID PRJEB44102)
Source: NCBI BioProject (ID PRJEB44102)
0 0
Project name: ATAC-seq of human gastric adenocarcinoma NCI-N87 cell line treated with lapatinib
Description: To investigate initial changes to chromatin accessibility associated with resistance to lapatinib, we performed ATAC-seq on NCI-N87 cells treated with 250nM lapatinib for 24 hours and vehicle control (DMSO) for 24 hours.
Data type: Other
Sample scope: Monoisolate
Organization: the university of manchester
Last updated: 2022-09-27